Rhythm Pharmaceuticals, Inc. (RYTM) Q2 FY25 Earnings Call

Q2 FY25 results, source: company transcript and SEC filings
QuarterQ2 FY25
Call date2025-08-06
Length50 minutes
EPS$-0.75
EPS consensus$-0.66
Revenue$48.5M

What changed, guidance prior to now, analyst Q&A candor and the case for and against are part of Core.

Other quarters: Q4 FY25

All RYTM earnings ยท Back to RYTM overview

Transcript produced by Signals.AI from the company's own earnings call audio. Not personalized investment advice.